Drug Affecting Metabolism by Rinku
Drug Affecting Metabolism by Rinku
Drug Affecting Metabolism by Rinku
Presenter : -
Rinku Kundu (B.pharm)
Dr Swaroop HS copyighted 1
Outline
• Introduction
• Phases of Metabolism
• Phase I Metabolism
• Cytochrome P family
• Phase II Metabolism
• Factors affecting Biotransformation
Dr Swaroop HS copyighted 2
Introduction
• Biotransformation: Chemical alteration of
the drug in body that converts nonpolar
or lipid soluble compounds to polar or
lipid insoluble compounds
• Consequences of biotransformation
• Active drug Inactive metabolite :
Pentobarbitone, Morphine, Chloramphenicol
• Active drug Active metabolite: Phenacetin
• Inactive drug active metabolite: Levodopa
Dr Swaroop HS copyighted 3
Phases of Metabolism
• Phase I
• Functionalization reactions
• Converts the parent drug to a more polar
metabolite by introducing or unmasking a
functional group (-OH, -NH2, -SH).
• Phase II
• Conjugation reactions
• Subsequent reaction in which a covalent
linkage is formed between a functional
group
on the parent compound or Phase I
metabolite and an endogenous substrate
such
as glucuronic acid, sulfate, acetate, or an
amino acid
Dr Swaroop HS copyighted 4
Phases of Metabolism
Hydrolytic Reactions
Esters, amides, epoxides Oxidation
and Aromatic moieties, Olefins
arene oxides by epoxide hydrase Benzylic & allylic C atoms
and a-C of C=O and C=N
Phase II - At aliphatic and alicyclic C
Phase I - C-Heteroatom system
Conjugation
Functionalization C-N (N-dealkylation, N-
oxide formation, N-
hydroxylation)
C-O (O-dealkylation)
Drug S-dealkylation
Metabolism S-oxidation, desulfuration
Oxidation of alcohols and
aldehydes,
Conjugation Miscellaneous
Glucuronic acid Reduction
Sulfate, Glycine and other AA Aldehydes and ketones
Glutathione or mercapturic acid Nitro and azo
Acetylation, Methylation Miscellaneous
Dr Swaroop HS copyighted 5
Phase I / Non Synthetic Reactions
Oxidation
• Addition of oxygen/ negatively charged radical
or removal of hydrogen/ positvely charged
radical.
• Reactions are carried out by group of mono-
oxygenases in the liver.
Dr Swaroop HS copyighted 6
Cytochrome P450 enzymes
• Monooxygenase enzyme family
• Major catalyst: Drug and endogenous
compound oxidations in liver, kidney, G.I. tract,
skin and lungs.
• Location: smooth endoplasmic reticulum.
• The reductase serves as the electron source for
the oxidative reaction cycle
Dr Swaroop HS copyighted 7
Cytochrome P
family
• Multiple CYP gene families have been identified in
humans, and the categoriezed based on protein
sequence homology
• Most of the drug metabolizing enzymes are in CYP
1, 2, & 3 families .
• Frequently, two or more enzymes can catalyze the
same type of oxidation, indicating redundant and
broad substrate specificity.
Dr Swaroop HS copyighted 8
Reduction
• Converse of oxidation
• Addition of Hydrogen / positively charged radical
or removal of Oxygen / negatively charged
radical
• Drugs primarily reduced are chloralhydrate,
chloramphenicol, halothane.
Dr Swaroop HS copyighted 9
MICROSOMAL REDUCTION
O OH
B.KETO Reduction - R-C-R1 R-CH-R1
Cortisone to Hydrocortisone,
C. AZO Reduction
Prontosil to Sulfanilamide
• Cyclization
• Formation of ring structure from a straight
chain compound
• E.g. Proguanil
• Decyclization
• Opening up of ring structure of the cyclic
drug molecule
• E.g. Barbiturates, Phenytoin.
Dr Swaroop HS copyighted 13
PHASE II REACTIONS
CONJUGATION
/ TRANSFER
Drug / phase I metabolite combines with
endogenous substance derived from
carbohydrates/ proteins.
covalent bond formation between
functional group
of drug & endogenous substrate
Endogenous-Glucuronic acid,Amino acids,
Sulfates,Acetates,Glutathione
Represent terminal inactivation – True
detoxification
reactions.
Conjugates-
hydrophilic
ionized,
↑mol.weight,
inactive
Endogenous substrates -
Steroid,Thyroxine,Bilirubin
2. ACETYLATION
Drugs with Amino or Hydrazine
groups - INH,PAS,Hydralazine,Sulfonamides
Procainamide,Dapsone.